»  Search

 


Advanced search


»  Quicklinks



»  Kontakt

B·R·A·H·M·S GmbH

Neuendorfstrasse 25
D-16761 Hennigsdorf

Tel: +49 - 3302 - 883 - 0
Fax: +49 - 3302 - 883 - 100
www: www.brahms.de
email: info.brahms@thermofisher.com


BRAHMS KRYPTOR compact
BRAHMS KRYPTOR

B·R·A·H·M·S KRYPTOR systems are fully automated random-access immunoassay systems. They offer optimal analytical precision as well as maximum economic efficiency.

B·R·A·H·M·S KRYPTOR compact   B·R·A·H·M·S KRYPTOR 

Our latest B·R·A·H·M·S KRYPTOR compact, equipped with cutting-edge technology, was developed to meet the needs of today's laboratories.

 

The B·R·A·H·M·S KRYPTOR is our flagship product for laboratory diagnostics and has proven itself over the years..

[learn more]

 

[learn more]

»  News

11/3/2011 - Software-Update: Thermo Scientific B·R·A·H·M·S Fast Screen pre I plus V 1.3 for all KRYPTOR systems

Thermo Scientific Biomarkers has brought an Update of the CE marked prenatal screening software B·R·A·H·M·S Fast Screen pre I plus onto the market. The new version 1.3 of the prenatal screening software is available as of November 2011 - currently deliverable in the following languages: German, English and French.

7/1/2011 - Thermo Scientific Biomarkers launches new assay: Thermo Scientific B·R·A·H·M·S TRAK human KRYPTOR

Thermo Scientific Biomarkers launched the automated TRAK human KRYPTOR assay in countries that accept CE certification. This assay is highly specific for the autoimmune disorder Graves´ disease.

11/24/2009 - B·R·A·H·M·S-Forum: Workshop on thyroid cancer big success

Hennigsdorf / Berlin 24.11.2009. At the invitation of B·R·A·H·M·S over 50 medics and scientists made their way to Berlin on November 6 and 7 to get an update on most recent developments in the field of thyroid cancer.

10/1/2009 - Competition Authorities approve Acquisition of B·R·A·H·M·S by Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) has acquired all of the shares of B·R·A·H·M·S Holding GmbH. The contractual merger resulting from this transaction was announced at the beginning of September. After a four-week inspection, the competent supervisory authorities have now also consented to the agreement.

9/15/2009 - The struggle against bacterial resistance and increasing medical costs:

ProHOSP study demonstrates the value of Procalcitonin marker for lower respiratory tract infections

This website is outside the U.S.
Products and/or uses listed may not be available to our customers in the U.S.
Please visit our US Website http://www.brahms-usa.com for detailed information on product availability in the U.S.